corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 6154

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Maher EA.
An analysis of finder's fees in clinical research.
CMAJ 1994 Jan 15; 150:(2):252-6
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=8287347


Abstract:

(Limited to parts of article dealing with promotion.) Finder’s fees which usually range from $50 to $200 per patient may cumulatively represent a substantial sum of money. Finder’s fees for cancer trials alone may amount to $2.6 million annually. Is it ethical for physicians to create a situation in which they receive incentive payments for enrolling patients in clinical trials and then pass the cost of this practice on to the patients? This question raises an often-cited argument for re-examining the relationship between the pharmaceutical industry and physicians, that the mere suggestion of conflict of interest tarnishes the image of the medical profession and clinical research.

Keywords:
Clinical Trials/economics Conflict of Interest Costs and Cost Analysis Decision Making Ethics, Medical Human Experimentation* Humans Research/economics* Research Support/economics* *analysis/bioethics/ reimbursement to doctors/ patients/ETHICAL ISSUES IN PROMOTION: PAYMENTS IN STUDIES

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend